Efficient Inhibition of Emerging SARS-CoV-2 Variants Including NB.1.8.1, XFG and BA.3.2 by a Fusion Inhibitor HY3000 Peptide

Efficient Inhibition of Emerging SARS-CoV-2 Variants Including NB.1.8.1, XFG and BA.3.2 by a Fusion Inhibitor HY3000 Peptide | AMiner